2 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone Trazodone, Placebo - Postpartum Depression | Phase 1 | Withdrawn | Verinder Sharma | 2025-04-17 | 2025-04-04 | |
| A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH) fibrinogen concentrate, Placebo - Postpartum Hemorrhage | Phase 1 / Phase 2 | Withdrawn | Yale University | 2021-01-01 | 2021-03-15 |
Depression, Postpartum (1) · Postpartum Hemorrhage (1) · Thrombosis (1)
Female Urogenital Diseases and Pregnancy Complications (2) · Pregnancy Complications (2) · Urogenital Diseases (2) · Cardiovascular Diseases (1) · Depressive Disorder (1) · Embolism and Thrombosis (1) · Hemorrhage (1) · Mental Disorders (1) · Mood Disorders (1) · Obstetric Labor Complications (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Uterine Hemorrhage (1) · Vascular Diseases (1)
Fibrinogen (1) · Sodium Chloride (1) · Trazodone (1)
Verinder Sharma (1) · Yale University (1)
Canada (1)
Michael J Paidas, MD (1) · Verinder Sharma, MB (1)